Showing results (311-320 of 481) with videos related to
Sort By:
Pageof 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group StudySarah Alexander, John A Kairalla, Sumit Gupta, et al.Research Square|July 28, 2023
Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in ChildrenCarolin Escherich, Wenan Chen, Yizhen Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology groupNyla A Heerema, Andrew J Carroll, Meenakshi Devidas, et al.Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.Clinical Nephrology|January 22, 2019
Changes in primary glomerulonephritis in Singapore over four decadesKeng-Thye Woo, Choong-Meng Chan, Cynthia Lim, et al.Blood|March 6, 2024
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in childrenCarolin S Escherich, Wenan Chen, Yizhen Li, et al.Pediatric Blood & Cancer|November 20, 2014
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology GroupWanda L Salzer, Tamekia L Jones, Meenakshi Devidas, et al.Blood|September 28, 2006
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R Schultz, D Jeanette Pullen, Harland N Sather, et al.Blood|November 15, 2014
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemiaElliot Stieglitz, Camille B Troup, Laura C Gelston, et al.Pageof 49